Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.70
Delayed Data
As of 10:54am ET
 0.00 / 0.00%
Today’s Change
0.97
Today|||52-Week Range
2.12
-10.05%
Year-to-Date

Today’s Trading

Previous close1.70
Today’s open1.72
Day’s range1.66 - 1.75
Volume287,442
Average volume (3 months)1,023,145
Market cap$256.3M
Dividend yield--
Data as of 10:54am ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...-0.27-2.35%
ECYTEndocyte Inc-0.12-1.92%
ADXSAdvaxis Inc+0.38+3.42%
EGLTEgalet Corp-0.51-3.36%
Data as of 11:09am ET, 03/06/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account